Diabetes puts myocardial n-3 fatty acid status at risk in the absence of supplementation in the rat.
McLennan
P L
PL
CSIRO Division of Human Nutrition, Adelaide, Australia. petermcl@uow.edu.au
Raederstorff
D
D
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism / Q000503:physiopathology*; D004041:Dietary Fats; D004042:Dietary Fats, Unsaturated; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids; D015525:Fatty Acids, Omega-3 / Q000378:metabolism*; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D000069463:Olive Oil; D010938:Plant Oils; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D004041:Dietary Fats; D004042:Dietary Fats, Unsaturated; D015525:Fatty Acids, Omega-3; D000069463:Olive Oil; D010938:Plant Oils; D004281:Docosahexaenoic Acids